Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial 
Cancel anytime
- Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
HSIC 
Henry Schein Inc (HSIC)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
09/12/2025: HSIC (1-star) is currently NOT-A-BUY. Pass it for now.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
16 Analysts rated it
Moderately tracked stock, growing coverage, gaining market and investor attention.
1 Year Target Price $73.23
1 Year Target Price $73.23
| 3 | Strong Buy |
| 4 | Buy |
| 8 | Hold |
| 0 | Sell |
| 1 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -25.94% | Avg. Invested days 39 | Today’s Advisory PASS |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 09/12/2025 |
Key Highlights
Company Size Mid-Cap Stock | Market Capitalization 8.37B USD | Price to earnings Ratio 22.19 | 1Y Target Price 73.23 |
Price to earnings Ratio 22.19 | 1Y Target Price 73.23 | ||
Volume (30-day avg) 16 | Beta 0.86 | 52 Weeks Range 60.56 - 82.49 | Updated Date 09/14/2025 |
52 Weeks Range 60.56 - 82.49 | Updated Date 09/14/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 3.11 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Revenue by Geography
Geography revenue - Year on Year
Earnings Date
Report Date - | When - | Estimate - | Actual - |
Profitability
Profit Margin 3.05% | Operating Margin (TTM) 5.4% |
Management Effectiveness
Return on Assets (TTM) 4.54% | Return on Equity (TTM) 8.12% |
Valuation
Trailing PE 22.19 | Forward PE 13.26 | Enterprise Value 11581732145 | Price to Sales(TTM) 0.66 |
Enterprise Value 11581732145 | Price to Sales(TTM) 0.66 | ||
Enterprise Value to Revenue 0.91 | Enterprise Value to EBITDA 12.43 | Shares Outstanding 121268000 | Shares Floating 101946704 |
Shares Outstanding 121268000 | Shares Floating 101946704 | ||
Percent Insiders 0.87 | Percent Institutions 114.26 |
Upturn AI SWOT
Henry Schein Inc
Company Overview
History and Background
Henry Schein, Inc. was founded in 1932. Originally a drugstore in Queens, New York, it evolved into a leading distributor of healthcare products and services to office-based dental, animal health, and medical practitioners.
Core Business Areas
- Dental: Distributes dental products, including equipment, consumable supplies, and technology solutions to dental practices and laboratories.
- Animal Health: Provides animal health products, including pharmaceuticals, vaccines, diagnostics, and equipment to veterinary practices.
- Medical: Offers medical supplies, equipment, and pharmaceuticals to physicians, surgery centers, and other healthcare providers.
- Technology and Value-added Services: Provides technology solutions, including practice management software, e-commerce platforms, and data analytics to healthcare professionals.
Leadership and Structure
Stanley M. Bergman is the Chairman and Chief Executive Officer. The company operates with a decentralized management structure with various business units focused on specific markets and product lines.
Top Products and Market Share
Key Offerings
- Dental Consumables: Includes dental materials, infection control products, and instruments. Competitors include Patterson Companies (PDCO), Benco Dental, and Straumann. Market share data specific to dental consumables varies geographically and across specific product categories. Estimated revenue contribution of 30-40% of dental segment revenue. Competitors: Patterson Companies (PDCO), Benco Dental, Straumann (STMN.SW).
- Dental Equipment & Technology: Encompasses dental chairs, imaging systems, CAD/CAM systems, and practice management software. Competitors include Planmeca, Dentsply Sirona (XRAY). The revenue contribution is estimated to be 20-30% of the dental segment revenue. Competitors: Dentsply Sirona (XRAY), Planmeca.
- Animal Health Pharmaceuticals and Vaccines: Includes prescription and over-the-counter medications, vaccines, and parasiticides. Competitors include Zoetis (ZTS), Elanco (ELAN). Revenue Contribution estimated 40% of Animal Health Segment revenue. Competitors: Zoetis (ZTS), Elanco (ELAN).
- Medical Examination Supplies: Includes gloves, masks, gowns, and other disposable items used in medical examinations. Competitors include McKesson (MCK), Cardinal Health (CAH). Revenue contribution is estimated to be 30-40% of Medical segment revenue. Competitors: McKesson (MCK), Cardinal Health (CAH).
Market Dynamics
Industry Overview
The healthcare distribution industry is characterized by consolidation, increasing regulatory requirements, and growing demand for integrated solutions. The industry is driven by an aging population, technological advancements, and expanding access to healthcare.
Positioning
Henry Schein, Inc. is positioned as a leading global provider of healthcare solutions. Its competitive advantages include a broad product portfolio, extensive distribution network, and strong relationships with healthcare professionals.
Total Addressable Market (TAM)
The global healthcare distribution market is estimated to be in the hundreds of billions of dollars. Henry Schein, Inc. is well-positioned to capture a significant share of this market, focusing on dental, animal health, and medical segments.
Upturn SWOT Analysis
Strengths
- Global Distribution Network
- Broad Product Portfolio
- Strong Customer Relationships
- Brand Recognition
- Established Supply Chain
Weaknesses
- Exposure to Currency Fluctuations
- Dependence on Key Suppliers
- Integration Risks from Acquisitions
- Highly Competitive Market
- Fluctuating Regulatory Landscape
Opportunities
- Expansion into Emerging Markets
- Growth in Digital Healthcare Solutions
- Strategic Acquisitions and Partnerships
- Increasing Demand for Preventative Care
- Telemedicine
Threats
- Economic Downturns
- Increased Competition from Online Retailers
- Changes in Healthcare Regulations
- Disruptive Technologies
- Supply Chain Disruptions
Competitors and Market Share
Key Competitors
- PDCO
- XRAY
- ZTS
- MCK
- CAH
- ELAN
Competitive Landscape
Henry Scheinu2019s advantages include its global scale, diverse product offerings, and strong relationships with healthcare professionals. Disadvantages can include competition from larger distributors and online retailers.
Major Acquisitions
Elite Dental Partners
- Year: 2018
- Acquisition Price (USD millions): 495
- Strategic Rationale: Expanded Henry Schein's presence in the dental service organization (DSO) market.
Growth Trajectory and Initiatives
Historical Growth: Henry Schein has historically grown through a combination of organic growth and acquisitions.
Future Projections: Analyst estimates and company guidance provide insights into HSIC's future growth prospects.
Recent Initiatives: Henry Schein has focused on expanding its digital healthcare solutions and making strategic acquisitions to strengthen its market position.
Summary
Henry Schein Inc. is a stable and well-established healthcare distributor with a diversified business across dental, animal health, and medical markets. The company benefits from its global reach and strong customer relationships, but it faces risks from competition and regulatory changes. Its growth strategy includes strategic acquisitions and expansion into digital solutions. The company's performance and outlook appear solid, with a few competitive threats.
Peer Comparison
Sources and Disclaimers
Data Sources:
- SEC Filings
- Company Investor Relations
- Financial News Outlets
- Analyst Reports
Disclaimers:
The information provided is for informational purposes only and does not constitute investment advice. Market share data is approximate and may vary based on sources and definitions. Investment decisions should be based on thorough research and consultation with a financial advisor.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Henry Schein Inc
Exchange NASDAQ | Headquaters Melville, NY, United States | ||
IPO Launch date 1995-11-03 | Executive Chairman & CEO Mr. Stanley M. Bergman CPA | ||
Sector Healthcare | Industry Medical Distribution | Full time employees 25000 | Website https://www.henryschein.com |
Full time employees 25000 | Website https://www.henryschein.com | ||
Henry Schein, Inc. provides health care products and services to office-based dental and medical practitioners, and alternate sites of care worldwide. It operates through Global Distribution and Value-Added Services; Global Specialty Products; and Global Technology segments. The company offers dental merchandise, including infection-control products, handpieces, preventatives, impression materials, composites, anesthetics, teeth, dental implants, gypsum, acrylics, articulators, abrasives, and PPE products; dental equipment, such as dental chairs, delivery units and lights, digital dental laboratories, X-ray supplies and equipment, and high-tech and digital restoration equipment, as well as equipment repair; and branded and generic pharmaceuticals, vaccines, surgical products, diagnostic tests, and vitamins. It also provides financial services on a nonrecourse basis, education services for practitioners, consulting, and other services; and consumable merchandise under its own brand. In addition, the company manufactures, markets, and sells dental implant and biomaterial products; and endodontic, orthodontic and orthopedic products and other health care-related products and services. Further, it is involved in the development and distribution of practice management software, e-services, and other products to health care providers. The company serves customers in dental practices, laboratories, physician practices, and ambulatory surgery centers, as well as government, institutional health care clinics and other alternate care clinics. Henry Schein, Inc. was founded in 1932 and is headquartered in Melville, New York.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.